Research Article
Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin’s Lymphoma and Role of β2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China
Figure 2
Comparisons of β2-MG level in two efficacy groups: (a) CR+PR vs. SD+PD before treatment; (b) CR+PR vs. SD+PD after treatment.
(a) |
(b) |